News

Fintel reports that on July 25, 2025, UBS upgraded their outlook for Nasdaq (NasdaqGS:NDAQ) from Neutral to Buy. Analyst ...
Fintel reports that on July 25, 2025, Baird downgraded their outlook for Oscar Health (NYSE:OSCR) from Outperform to Neutral.